计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
Moligand™ 级 提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
避光,-20°C储存,充氩。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 35 篇同行评审文献引用。
Lovastatin (Mevinolin) 是一种用于降低胆固醇的细胞渗透性的 HMG-CoA 还原酶 抑制剂。
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机杂环化合物 |
| 类(Class) | 内酯 |
| 亚类(Subclass) | δ戊内酯 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | δ戊内酯 |
| 其他上位类(Alternative Parents) | 脂肪酸酯 氧烷 二羧酸及其衍生物 仲醇 羧酸酯 氧环化合物 有机氧化物 碳氢化合物衍生物 羰基化合物 |
| 分子骨架(Molecular Framework) | 脂肪族杂多环化合物 |
| 取代基(Substituents) | 羟基苯甲酸酯 - 脂肪族杂多环化合物 - 羰基 - 羧酸衍生物 - 羧酸酰胺 - δ-戊酸内酯 - δ-戊酸内酯 - 二羧酸或其衍生物 - 脂肪酸酯 - 脂肪酰基 - 烃衍生物 - 有机氧化物 - 有机氧化合物 - 有机氧化合物 - 氧杂环 - 氧杂环丁烷 - 醛基 |
| 描述(Description) | 该化合物属于有机化合物中的δ-戊内酯类。这类环状有机化合物含有氧杂环丁烷-2-酮结构单元。 |
| 外部描述符(External Descriptors) | polyketide - fatty acid ester - delta-lactone - carbobicyclic compound - statin (naturally occurring) |
| ALogP | 4.3 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
H302: 吞食有害
H317: 可能引起皮肤过敏反应
H351: 怀疑引起遗传缺陷
H361: 怀疑破坏生育力或未出生的孩子
H372: 通过长时间或反复暴露对器官造成损害
P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾
P264: 处理后要彻底洗手。
P270: 使用本产品时,请勿进食、饮水或吸烟。
P272: 被污染的工作服不允许离开工作场所
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。
P321: 特殊处理(请参阅此标签上的...)。
P330: 漱口
P302+P352: 如皮肤沾染:用水充分清洗。
P333+P313: 如发生皮肤刺激或皮疹:求医/就诊。
P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。
P405: 密闭存放
P501: 将内容物/容器处理到。。。
P203: 使用前,获取、阅读并遵守所有安全说明。
P301+P317: 如果被吞咽:请寻求医疗帮助。
P318: 如果暴露或担心,请就医。
P319: 如果你感到不适,请寻求医疗帮助。
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 | |
| 分析证书 | L107709 |
| 1. Gai Gao, Jie Zhao, Jing Ding, Shuyan Liu, Yanyan Shen, Changxin Liu, Huifen Ma, Yu Fu, Jiangyan Xu, Yiran Sun, Xiaowei Zhang, Zhenqiang Zhang, Zhishen Xie. (2023) Alisol B regulates AMPK/mTOR/SREBPs via directly targeting VDAC1 to alleviate hyperlipidemia. PHYTOMEDICINE, [PMID:38520833] [10.1016/j.phymed.2023.155313] |
| 2. Xiang Li, Rongxia Li, Xueyu Wang, Xinying Zhang, Zhiyi Xiao, Haibo Wang, Wenhui Sun, Hao Yang, Peng Yu, Qing Hu, Qinghui Guo, Hua Sun. (2023) Effects and mechanism of action of Chrysanthemum morifolium (Jinsi Huangju) on hyperlipidemia and non-alcoholic fatty liver disease. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, [PMID:37099836] [10.1016/j.ejmech.2023.115391] |
| 3. Xiaoyi Shi, Meng Li, Qiming Huang, Liuming Xie, Zhibing Huang. (2023) Monacolin K Induces Apoptosis of Human Glioma U251 Cells by Triggering ROS-Mediated Oxidative Damage and Regulating MAPKs and NF-κB Pathways. ACS Chemical Neuroscience, [PMID:36917811] [10.1021/acschemneuro.3c00104] |
| 4. Bo Wei, Yuanfang Li, Meiying Ao, Wenxiang Shao, Kun Wang, Tong Rong, Yun Zhou, Yong Chen. (2022) Ganglioside GM3-Functionalized Reconstituted High-Density Lipoprotein (GM3-rHDL) as a Novel Nanocarrier Enhances Antiatherosclerotic Efficacy of Statins in apoE−/− C57BL/6 Mice. Pharmaceutics, 14 (11): (2534). [PMID:36432725] [10.3390/pharmaceutics14112534] |
| 5. Qing Sun, Li Li, Quan Zhou. (2022) Effects of Ethanolic Extract of Schisandra sphenanthera on the Pharmacokinetics of Rosuvastatin in Rats. Drug Design Development and Therapy, [PMID:35607596] [10.2147/DDDT.S364234] |
| 6. Pan Zhenzhen, Wang Kai, Wang Xiniao, Jia Zhirong, Yang Yuqi, Duan Yalei, Huang Lianzhan, Wu Zhuo-Xun, Zhang Jian-ye, Ding Xuansheng. (2022) Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression. Molecular Cancer, 21 (1): (1-17). [PMID:35303882] [10.1186/s12943-022-01547-3] |
| 7. Ping-Ting Xiao, Yu-Jia Kuang, Shi-Yu Liu, Zhi-Shen Xie, Jin-Hua Hao, E-Hu Liu. (2022) The antihyperlipidemic equivalent combinatorial components from peel of Citrus reticulata ‘Chachi’. JOURNAL OF FOOD AND DRUG ANALYSIS, [PMID:35647727] [10.38212/2224-6614.3388] |
| 8. Bei Yan, Lei Chen, Yanhui Wang, Jiacheng Zhang, Hui Zhao, Qinglian Hua, Shengjie Pei, Zihang Yue, Hui Liang, Huaqi Zhang. (2022) Preventive Effect of Apple Polyphenol Extract on High-Fat Diet-Induced Hepatic Steatosis in Mice through Alleviating Endoplasmic Reticulum Stress. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, [PMID:35227062] [10.1021/acs.jafc.1c07733] |
| 9. Zhishen Xie, Er-wen Li, Gai Gao, Yueyue Du, Mengyao Wang, Hui Wang, Pan Wang, Yonghui Qiao, Yunfang Su, Jiangyan Xu, Xiaowei Zhang, Zhenqiang Zhang. (2022) Zexie Tang targeting FKBP38/mTOR/SREBPs pathway improves hyperlipidemia. JOURNAL OF ETHNOPHARMACOLOGY, [PMID:35151834] [10.1016/j.jep.2022.115101] |
| 10. Andy Wijaya, Yi Wang, Dan Tang, Yuan Zhong, Boyan Liu, Meng Yan, Quhui Jiu, Wei Wu, Guixue Wang. (2021) A study of lovastatin and L-arginine co-loaded PLGA nanomedicine for enhancing nitric oxide production and eNOS expression. Journal of Materials Chemistry B, 10 (4): (607-624). [PMID:34994373] [10.1039/D1TB01455B] |
| 11. Hong Zhang, Shaoting Sang, Huimin Xu, Linghua Piao, Xiande Liu. (2021) Lovastatin suppresses bacterial therapy-induced neutrophil recruitment to the tumor by promoting neutrophil apoptosis. Journal of Functional Foods, [10.1016/j.jff.2021.104693] |
| 12. Ying Xu, Yunxia Dong, Cong Wang, Qian Jiang, Haichao Chu, Yue Tian. (2021) Lovastatin attenuates sevoflurane-induced cognitive disorder in aged rats via reducing Aβ accumulation. NEUROCHEMISTRY INTERNATIONAL, [PMID:34048842] [10.1016/j.neuint.2021.105078] |
| 13. Ping-Ting Xiao, Zhi-Shen Xie, Yu-Jia Kuang, Shi-Yu Liu, Chun Zeng, Ping Li, E-Hu Liu. (2021) Discovery of a potent FKBP38 agonist that ameliorates HFD-induced hyperlipidemia via mTOR/P70S6K/SREBPs pathway. Acta Pharmaceutica Sinica B, [PMID:34900535] [10.1016/j.apsb.2021.03.031] |
| 14. Na Deng, Ziqian He, Ruixue Guo, Bisheng Zheng, Tong Li, Rui Hai Liu. (2020) Highland Barley Whole Grain (Hordeum vulgare L.) Ameliorates Hyperlipidemia by Modulating Cecal Microbiota, miRNAs, and AMPK Pathways in Leptin Receptor-Deficient db/db Mice. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, [PMID:32985184] [10.1021/acs.jafc.0c04780] |
| 15. Guihua Yan, Yunchao Feng, Zhebang Gao, Xianhai Zeng, Wenjing Hong, Wenjie Liu, Yong Sun, Xing Tang, Tingzhou Lei, Lu Lin. (2019) Stable and Biocompatible Cellulose-Based CaCO3 Microspheres for Tunable pH-Responsive Drug Delivery. ACS Sustainable Chemistry & Engineering, [10.1021/acssuschemeng.9b05144] |
| 16. Kun Wang, Chuan Yu, Yang Liu, Wendiao Zhang, Yanan Sun, Yong Chen. (2018) Enhanced Antiatherosclerotic Efficacy of Statin-Loaded Reconstituted High-Density Lipoprotein via Ganglioside GM1 Modification. ACS Biomaterials Science & Engineering, [PMID:33418777] [10.1021/acsbiomaterials.7b00871] |
| 17. Yu Zhang, Shiguo Chen, Chaoyang Wei, Jianchu Chen, Xingqian Ye. (2016) Proanthocyanidins from Chinese bayberry (Myrica rubra Sieb. et Zucc.) leaves regulate lipid metabolism and glucose consumption by activating AMPK pathway in HepG2 cells. Journal of Functional Foods, [10.1016/j.jff.2016.12.030] |
| 18. Zu-Guo Zheng, Ya-Ping Zhou, Xin Zhang, Pyone Myat Thu, Zhi-Shen Xie, Chong Lu, Tao Pang, Bin Xue, Da-Qian Xu, Yan Chen, Xiao-Wei Chen, Hui-Jun Li, Xiaojun Xu. (2016) Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation. BIOCHEMICAL PHARMACOLOGY, [PMID:27816546] [10.1016/j.bcp.2016.10.016] |
| 19. Zhi-Shen XIE, Ling-Jun ZHONG, Xiao-Meng WAN, Meng-Ning LI, Hua YANG, Ping LI, Xiao-Jun XU. (2016) Petroleum ether sub-fraction of rosemary extract improves hyperlipidemia and insulin resistance by inhibiting SREBPs. Chinese Journal of Natural Medicines, [PMID:28236404] [10.1016/S1875-5364(16)30089-9] |
| 20. Mengdi Zhang, Zhaoxin Wang, Siyu Hao, Lei Hao, Xinying Zhang, Peng Yu, Hua Sun. (2020) Synthesis of natural 3′-Prenylchalconaringenin and biological evaluation of ameliorating non-alcoholic fatty liver disease and metabolic syndrome. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, [PMID:32791402] [10.1016/j.ejmech.2020.112649] |
| 21. Junfeng Li, Min Guo, Cuiping Yuan, Tiezhu Li, Jie Zhang, Li Ren. (2024) Ameliorative potential of ellagic acid via PPARγ against hyperlipidemia: Insights from mice and zebrafish. Food Bioscience, [10.1016/j.fbio.2024.105582] |
| 22. Jie Zhao, Gai Gao, Jing Ding, Wei Liu, Tao Wang, Liang Zhao, Jiangyan Xu, Zhenqiang Zhang, Xiaowei Zhang, Zhishen Xie. (2024) Astragaloside I Promotes Lipophagy and Mitochondrial Biogenesis to Improve Hyperlipidemia by Regulating Akt/mTOR/TFEB Pathway. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, [PMID:39226078] [10.1021/acs.jafc.4c03172] |
| 23. Qiuyan Jiang, Tiehua Zhang, Yuan Liang, Jie Zhang. (2024) Baicalein ameliorates lipid accumulation in HepG2 cells via the pregnane X receptor signaling pathway. Food Bioscience, [10.1016/j.fbio.2024.104482] |
| 24. Lin Fu, Hengxin Ren, Chaoxing Wang, Yaxin Zhao, Bohang Zou, Xiangyu Zhang. (2025) Formation of PEG-PLGA Microspheres for Controlled Release of Simvastatin and Carvacrol: Enhanced Lipid-Lowering Efficacy and Improved Patient Compliance in Hyperlipidemia Therapy. Polymers, 17 (5): (574). [PMID:40076067] [10.3390/polym17050574] |
| 25. Kun Miao, Yawei Zhao, Ning Xue. (2024) Gkongensin A, an HSP90β inhibitor, improves hyperlipidemia, hepatic steatosis, and insulin resistance. Heliyon, [PMID:38655315] [10.1016/j.heliyon.2024.e29367] |
| 26. Guangjie Zhang, Huiying Zhang, Ruiyi Dong, Hongmei Zhao, Junfeng Li, Weiming Yue, Zheng Ma. (2024) Oleanolic acid attenuates obesity through modulating the lipid metabolism in high-fat diet-fed mice. Food Science & Nutrition, [PMID:39479652] [10.1002/fsn3.4408] |
| 27. Zijun Tao, Jian Zhang, Fuge Niu, Huien Zhang, Zhongfa Chen, Shanfu Wang, Yuli Zhang, Jie Li, Peng Liu. (2024) Polygonati rhizoma fermentation by Monascus ruber and evaluation of fermentation products in vitro. PROCESS BIOCHEMISTRY, [10.1016/j.procbio.2024.07.013] |
| 28. Peiyu Xue, Xinyong You, Li Ren, Weiming Yue, Zheng Ma. (2024) PPARγ-mediated amelioration of lipid metabolism abnormality by kaempferol. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, [PMID:39278305] [10.1016/j.abb.2024.110154] |
| 29. Qian Hu, Mengyao Wang, Meng Chen, Jinjin Wang, Ting Niu. (2025) Toosendanin Induces Cell Cycle Arrest and Apoptosis to Suppress Diffuse Large B-Cell Lymphoma Growth by Inhibiting PI3Kα/β and PLK1 Signaling. PHYTOTHERAPY RESEARCH, [PMID:39949030] [10.1002/ptr.8439] |
| 30. Longkai Shi, Emad Karrar, Xingguo Wang. (2021) Sesamol ameliorates hepatic lipid accumulation and oxidative stress in steatosis HepG2 cells via the PPAR signaling pathway. JOURNAL OF FOOD BIOCHEMISTRY, 45 (11): (e13976). [PMID:34664288] [10.1111/jfbc.13976] |
| 31. Xing Zhang, Wen Shi, Hui He, Ruge Cao, Tao Hou. (2020) Hypolipidemic effects and mechanisms of Val-Phe-Val-Arg-Asn in C57BL/6J mice and 3T3-L1 cell models. Journal of Functional Foods, [10.1016/j.jff.2020.104100] |
| 32. Yuan-yuan Zhai, Qiang Wang, Qi-yao Nong, Mei-yu Gao, Ying Zhang, Qin-wen Xiao, Yuan Tian, Zun-jian Zhang, Feng-guo Xu, Pei Zhang. (2025) Pitavastatin overcomes multi-drug resistance in CRC and NSCLC by targeting the NRP1-ZFX axis. BIOCHEMICAL PHARMACOLOGY, [PMID:40684995] [10.1016/j.bcp.2025.117183] |
| 33. Li Haihua, Li Jiahe, Liu Ningjin, Li Huishan, Wang Jiarui, Zhang Rulan, Xue Jingyan, Kang Xiaotian, Guan Xinying, Lin Shiya, Zhang Ziyu, Kuang Jiaqi, Qian Chenlei, Zhou Pengfei. (2025) Synergistic enhancement of alkaloid biosynthesis in Catharanthus roseus CMCs via enzyme Inhibition and abiotic elicitation. PLANT CELL TISSUE AND ORGAN CULTURE, 162 (3): (1-12). [10.1007/s11240-025-03211-2] |
| 34. Jiaxuan Li, Yu Li, Xunyu Song, Yuxiao Wang, Yinxu Zhang, Xinghua Gao, Mingqian Tan, Wentao Su. (2025) Ulva lactuca Extracellular Vesicles Protect Against High-Fat Diet-Induced Intestinal Damage via Nrf2/Keap1/HO-1 Activation. Food & Function, [PMID:41355512] [10.1039/D5FO03126E] |
| 35. Liu Shu-yan, Zhang Xiao-wei, Gao Gai, Liu Chang-xin, Chen Hui, Fu Zhong-xue, Xu Jiang-yan, Wang Zhen-zhen, Zhang Zhen-qiang, Xie Zhi-shen. (2025) Pseudolaric Acid B Alleviates Non-alcoholic Fatty Liver Disease by Targeting PPARα to Regulate Lipid Metabolism and Promote Mitochondrial Biogenesis. Chinese Journal of Integrative Medicine, [PMID:40515882] [10.1007/s11655-025-3832-y] |